Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jul;21(4):335-42.
doi: 10.1111/anec.12389. Epub 2016 Jun 20.

Electrocardiographic Presentation, Cardiac Arrhythmias, and Their Management in β-Thalassemia Major Patients

Vincenzo Russo  1 , Anna Rago  1 , Andrea Antonio Papa  1 , Gerardo Nigro  1
Affiliations
Review

Electrocardiographic Presentation, Cardiac Arrhythmias, and Their Management in β-Thalassemia Major Patients

Vincenzo Russo et al. Ann Noninvasive Electrocardiol. 2016 Jul.

Abstract

Beta-thalassemia major (β-TM) is a genetic hemoglobin disorder characterized by an absent synthesis of globin chains that are essential for hemoglobin formation, causing chronic hemolytic anemia. Clinical management of thalassemia major consists in regular long-life red blood cell transfusions and iron chelation therapy to remove iron introduced in excess with transfusions. Iron deposition in combination with inflammatory and immunogenic factors is involved in the pathophysiology of cardiac dysfunction in these patients. Heart failure and arrhythmias, caused by myocardial siderosis, are the most important life-limiting complications of iron overload in beta-thalassemia patients. Cardiac complications are responsible for 71% of global death in the beta-thalassemia major patients. The aim of this review was to describe the most frequent electrocardiographic abnormalities and arrhythmias observed in β-TM patients, analyzing their prognostic impact and current treatment strategies.

Keywords: arrhythmias; beta-thalassemia; cardiac function; electrocardiography; heart; miocardial iron overload; thalassemic cardiomyopathy.

PubMed Disclaimer

References

    1. Thalassemia International Federation: Guidelines for the management of Transfusion Dependent Thalassemia, 3rd Edition (2014). [http://www.thalassemia.org.cy].
    1. Galanello R, Origa R. Betha‐thalassemia. Orphanet J Rare Dis 2010;5:11. - PMC - PubMed
    1. Borgna‐Pignatti C, Galanello R. Thalassemias and related disorders: Quantitative disorders of hemoglobin synthesis In Wintrobe MM Greer JP. (ed.): Wintrobe's Clinical Hematology, Volume 42, 11th Edition Philadelphia, Lippincott Williams & Wilkins, 2004, pp. 1319–1365.
    1. Borgna‐Pignatti C. The life of patients with thalassemia major. Haematologica 2010;95:345–348. - PMC - PubMed
    1. Olivieri NF. The beta‐thalassemias. N Engl J Med 1999;341:99–109. - PubMed